pyrroles has been researched along with Phlegmon in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Díaz Valle, D; García Caride, S; Marquina, G | 1 |
| Curiel, RE; Motzer, RJ; Patel, PH; Senico, PL | 1 |
1 trial(s) available for pyrroles and Phlegmon
| Article | Year |
|---|---|
Phase I study combining treatment with temsirolimus and sunitinib malate in patients with advanced renal cell carcinoma.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cellulitis; Diarrhea; Drug Eruptions; Female; Humans; Indoles; Infusions, Intravenous; Kidney Neoplasms; Male; Middle Aged; Pyrroles; Sirolimus; Stomatitis; Sunitinib; Thrombocytopenia; Treatment Outcome | 2009 |
1 other study(ies) available for pyrroles and Phlegmon
| Article | Year |
|---|---|
Preseptal cellulitis, intraocular inflammatory reaction and corneal persistent epithelial defect as side effects of avapritinib.
Topics: Aged; Antineoplastic Agents; Cellulitis; Epithelium, Corneal; Eye Diseases; Female; Gastrointestinal Stromal Tumors; Humans; Inflammation; Neoplasm Metastasis; Neoplasm Staging; Pyrazoles; Pyrroles; Receptor, Platelet-Derived Growth Factor alpha; Triazines | 2021 |